JDRF Blog

JDRF Launches First Center of Excellence, Aiming to Accelerate Type 1 Diabetes Research

Read More About JDRF Launches First Center of Excellence, Aiming to Accelerate Type 1 Diabetes Research

Semma Therapeutics, Backed by the JDRF T1D Fund, Acquired by Major Biopharma Company

In an exciting step forward in type 1 diabetes (T1D) research and development and for people with T1D, on September 3, 2019,...

Read More About Semma Therapeutics, Backed by the JDRF T1D Fund, Acquired by Major Biopharma Company

JDRF Urges Congress to Fund Diabetes Research

On June 4, JDRF’s President & CEO Aaron J. Kowalski, Ph.D., testified before the U.S. House of Representatives Committee on Energy &...

Read More About JDRF Urges Congress to Fund Diabetes Research

JDRF Top Advances Over the Past Year

Thanks to the efforts of our donors and volunteers, we have made a series of top advances in our fight to cure...

Read More About JDRF Top Advances Over the Past Year

Recent Articles

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

    Read more

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

    Read more

  • JDRF Clinical Trial Results Announced at the 55th EASD Meeting

    September 18, 2019

    A protein, called glucokinase (or GK), acts as a key regulator of sugar levels in the body. If blood glucose levels are...

    Read more

  • The Best of the Best: Researchers Unite at the 55th EASD Annual Meeting

    September 16, 2019

    Read more

  • FDA Approves Xeris Pharmaceuticals’ Glucagon to Treat Severe Hypoglycemia

    September 11, 2019

    “The approval of the GVOKE HypoPenTM is an important step forward for people with diabetes. Severe hypoglycemia is a terrifying and dangerous...

    Read more

  • JDRF Launches First Center of Excellence, Aiming to Accelerate Type 1 Diabetes Research

    September 4, 2019

    Read more

  • Semma Therapeutics, Backed by the JDRF T1D Fund, Acquired by Major Biopharma Company

    September 4, 2019

    In an exciting step forward in type 1 diabetes (T1D) research and development and for people with T1D, on September 3, 2019,...

    Read more

  • JDRF Innovative Clinical Trial Design Workshop

    August 27, 2019

    BMC Medicine 16: 29 (2018)

    Read more

  • Educators Align at the American Association of Diabetes Educators (AADE) Conference

    August 15, 2019

    Read more

  • The Type 1 Diabetes Digital Recipe Box

    August 14, 2019

    When you’re cooking to meet the needs of someone with type 1 diabetes (T1D), whether that be yourself, a family member or...

    Read more